Fathom Therapeutics (Series A)
Funding Details
Awarder
Inbox
Date Award
April 27, 2026
Vertical
Biotechnology
Funding Amount
$47,000,000
Company Info
Traction
The company has an active internal pipeline, multiple discovery partnerships, and has advanced its lead program into animal efficacy studies.
Founders
Huafeng Xu
Market
Pharmaceuticals
Location
New York, New York, USA
Coinvestors
Alexandria Venture Investments, Chemistry, Empire State Development's NY Ventures, Sutter Hill Ventures
Company Description

Fathom Therapeutics is a drug design company that uses physics-based simulations and AI to model protein motion and interactions at atomic resolution. Its Microcosmos platform simulates protein dynamics, producing the data needed to design small molecules with differentiated therapeutic effects and reduced off-target risk.

Links